- The Wall Street Journal•1 hour ago
Johnson & Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year—and 3.5% after discounts—in the health-products company’s first effort to address criticism ...
- Associated Press•1 hour ago
TRENTON, N.J. (AP) — Several big drugmakers are trying to quell the ongoing furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.
- Reuters•2 hours ago
Johnson & Johnson on Monday said the average list price of its drugs rose less than 10 percent each year since 2012, noting that the net price paid for the drugs, which includes discounts and rebates, was significantly lower. The company released a report with its price increase history in response to widespread outcry over high U.S. prices for prescription drugs. U.S. President Donald Trump has said drug companies are "getting away with murder" in what they charge the government for medicines.
JNJ : Summary for Johnson & Johnson Common Stock - Yahoo Finance
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||122.10 - 122.88|
|52 Week Range||105.04 - 126.07|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||20.64|
|Dividend & Yield||3.20 (2.61%)|
|1y Target Est||N/A|